According to a single-arm phase 2 clinical trial conducted by the University of Pittsburgh, UPMC Hillman Cancer Center and National Cancer Institute (NCI). Results published in Cancer Cellsupport the development of vidutolimod for the treatment of cutaneous melanoma and provide critical insights that could advance research into this drug for utilize in the treatment of […]
Prolonged sitting has long been associated with various health risks, including cardiovascular problems, which contributes to the popularity of standing desks among office workers. However, a recent study suggests that standing for long periods of time does not provide long-term cardiovascular benefits and may not be a better option. According to the latest test published […]
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated an adequate safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid tumors, according to interim data shared today at the European Society for Medical Oncology (ESMO) 2024 Congress by investigators at The University of Texas MD Anderson Cancer […]
Taking blood pressure (BP) medications in the evening does not reduce the risk of cardiovascular events or death compared to taking them in the morning, according to up-to-date research presented today at the Sizzling Line session during the ESC Congress 2024. “Evidence suggests that higher than normal nighttime blood pressure levels are associated with an […]
In a recent prospective observational cohort study published in eMedicineClinicalResearchers evaluated a modified total neoadjuvant treatment (TNT) regimen in patients with high-risk locally advanced rectal cancer (LARC) in Sweden. The modified TNT regimen was found to achieve similar complete response (CR) rates and lower neurotoxicity compared with the RAPIDO study, despite treating older patients with […]
